Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Quantitative assessment of microbiomes using ultra-fast MS/MS-free metaproteomics: Rhodococcus opacus 1CP

ABSTRACT: This study presents an adaptation of the novel ultrafast MS1-based method called DirectMS1 to characterization of the single microorganisms and microbiomes. Using DirectMS1 we demonstrate the blind identification (with no prior knowledge of the bacterias in the sample) of a single bacterial species and microbial compositions using two-step database search against the microbial part of SwissProt and TrEMBL (62Gb database size), the evaluation of fold changes in biomass of microorganisms between the metaproteomic samples, and the assessment of metabolic activity of Rhodococcus species responding to a change in growth conditions and cold shock.

INSTRUMENT(S):

ORGANISM(S): Rhodococcus Opacus

SUBMITTER: Tomiris Kusainova

LAB HEAD: Dr Irina A. Tarasova

PROVIDER: PXD050761 | Pride | 2026-08-07

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	B1_08092022_20220908202953.raw	Raw
	B2_08092022.raw	Raw
	B3_08092022.raw	Raw
	B4_08092022.raw	Raw
	B5_08092022.raw	Raw

Items per page:

1 - 5 of 26

Similar Datasets

Quantitative assessment of microbiomes using ultra-fast MS/MS-free metaproteomics: model 2

Project description:This study presents an adaptation of the novel ultrafast MS1-based method called DirectMS1 to characterization of the single microorganisms and microbiomes. Using DirectMS1 we demonstrate the blind identification (with no prior knowledge of the bacterias in the sample) of a single bacterial species and microbial compositions using two-step database search against the microbial part of SwissProt and TrEMBL (62Gb database size), the evaluation of fold changes in biomass of microorganisms between the metaproteomic samples, and the assessment of metabolic activity of Rhodococcus species responding to a change in growth conditions and cold shock.

2026-08-07 | PXD050887 | Pride

Quantitative assessment of microbiomes using ultra-fast MS/MS-free metaproteomics: model 1 and 3

2026-08-07 | PXD050587 | Pride

Quantitative assessment of microbiomes using ultra-fast MS/MS-free metaproteomics: Rhodococcus erythropolis X5

2026-08-07 | PXD050807 | Pride

DirectMS1Quant: ultrafast quantitative proteomics with MS/MS-free mass spectrometry. Part 2/2

Project description:Recently, we presented the DirectMS1 method of ultrafast proteome-wide analysis based on minute-long LC gradients and MS1-only mass spectra acquisition. Currently, the method provides the depth of human cell proteome coverage of 2500 proteins at 1% false discovery rate (FDR) when using 5-min LC gradients and 7.3 min runtime in total. While the standard MS/MS approaches provide 4000 to 5000 protein identifications within a couple of hours of instrumentation time, we advocate here that the higher number of identified proteins does not always translate into better quantitation quality of the proteome analysis. To further elaborate on this issue we performed one-by-one comparison of quantitation results obtained using DirectMS1 with three most popular MS/MS-based proteomic methods: label-free quantification (LFQ) and tandem mass tag (TMT) -based data dependent acquisition (DDA), and data independent acquisition (DIA). For the comparison we performed a series of proteome-wide analysis of well-characterized (ground truth) and real world biological samples, including a mix of UPS1 proteins spiked at different concentrations into E. coli digest used as a background and a set of glioblastoma cell lines. MS1-only data was analyzed using a novel quantitation workflow called DirectMS1Quant developed in this work. The results obtained in this study demonstrated comparable quantitation efficiency of 5 min DirectMS1 with both TMT and DIA methods utilizing 10 to 20-fold longer instrumentation time.

2023-08-25 | PXD033355 | Pride

DirectMS1Quant: ultrafast quantitative proteomics with MS/MS-free mass spectrometry. Part 1/2

2023-08-25 | PXD033350 | Pride

On the utility of ultrafast MS1-only proteomics in drug target discovery studies based on thermal proteome profiling method

Project description:Advances in high-throughput high-resolution mass spectrometry and the development of thermal proteome profiling approach (TPP) have made it possible to accelerate a drug target search. Since its introduction in 2014, TPP quickly became a method of choice in chemical proteomics for identifying drug-to-protein interactions on a proteome-wide scale and mapping the pathways of these interactions, thus, further elucidating the unknown mechanisms of action of a drug under study. However, the current TPP implementations based on tandem mass spectrometry (MS/MS), associated with employing lengthy peptide separation protocols and expensive labeling techniques for sample multiplexing limit the scaling of this approach for the ever growing variety of drug-to-proteome combinations at the faster pace. A variety of ultrafast proteomics methods have been developed in the last couple of years. Among them, DirectMS1 provides MS/MS-free quantitative proteome-wide analysis in a minute time scale, thus, opening the way for sample-hungry applications, such as TPP. In this work, we demonstrate the first implementation of the TPP approach using the ultrafast proteome-wide analysis based on DirectMS1. Using a drug topotecan, which is a known topoisomerase I inhibitor, the feasibility of the method for identifying drug targets at the whole proteome level was demonstrated for the ovarian cancer cell line.

2024-10-07 | PXD051712 | Pride

Ultrafast proteomics revealed everolimus-induced inhibition of 20S proteasome subunit

Project description:In this study, we compare the proteomic responses of three cell lines (A549, HCT116, and MCF-7) to treatment with three antitumor drugs (bortezomib, everolimus, and lonidamine), with a particular focus on the effects on the ubiquitin-proteasome system. Liquid chromatography–mass spectrometry (LC-MS) experiments for cellular samples were conducted using an Orbitrap Q Exactive HF mass spectrometer, and the data were analyzed utilizing the DirectMS1 method. Cellular samples treated with bortezomib and lonidamine served as negative and positive controls, respectively, while the samples treated with everolimus constituted the primary subject of investigation.

2026-07-20 | PXD060076 | Pride

Gene expression for Escherichia coli BW25113 exponential growth on minimal medium with eight different carbon sources: Glucose, Galactose, Glycerol, Gluconate, Fructose, Pyruvate, Succinate, Acetate.

Project description:This dataset contains the gene expression signature in triplicates of Escherichia coli BW25113 growing exponentially on eight different environments: minimal medium supplemented with 5 g/L of Glucose, Galactose, Glycerol, Gluconate, Fructose, Pyruvate, Succinate or Acetate as the sole carbon source.

2015-10-07 | E-MTAB-3392 | biostudies-arrayexpress

Effects of the Fnr homologue AadR on global gene expression

Project description:In order to define the AadR regulon we did transcriptome analysis of an aadR in frame-deletion mutant and compared to that of wild type. We found that AadR positively modulated expression of 43 genes, most of which are involved in degradation of aromatic acids under anaerobic conditions. It also activated expression of four genes encoding for unknown proteins and a possible DNA-binding stress protein. Furthermore, AadR repressed the expression of 100 genes, including fixK and many genes controlled by FixK, mainly those involved in a microaerobic lifestyle R. palustris strains were grown in defined medium anaerobically in light (photosynthetically) in sealed tubes with nitrogen gas in the headspace. Succinate and p-coumarate were provided as carbon sources.

2010-12-13 | E-GEOD-19093 | biostudies-arrayexpress

HeLa benchmark datasets DirectMS1 MSGF+

Project description:This technical dataset contains LC-MS runs of HeLa protein digest analyzed with a common shotgun proteomics pipeline based on MSGF+ and Percolator and DirectMS1 pipeline.

2023-09-25 | PXD045495 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data